Computational design of immunogenic peptide–ligand conjugates for targeted therapy against Nipah virus infection
A novel peptide-ligand conjugate (PLC) immunotherapeutic approach that exploits pre-existing immune responses in NiV-endemic populations to selectively target and eliminate infected cells is proposed.